Synaptogenix Inc (SNPX)

[xIdXd]

Let's say you're a director. You have one option giving you the right to purchase a share for 19 dollars.

If your company is in need of money and the stock price is at, let's say 10 dollars, you could still exercise your option and pay the company 19 dollars to receive 1 share.

Since you haven't sold your share yet, you have technically not lost any money yet, but your company would then have 19 more dollars to use.

Choosing to pay above market price is something directors could do if they believed there was still potential in the company, even if the trial fails, which makes sense considering that they are working on many more drugs than just Bryostatin.